Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596657 · ClinicalTrials.gov registry record · NA
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
A NA study of COVID-19 and Respiratory Tract Infections, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 877
- Enrollment target
- 1
- Study location
NCT04596657: Completed NA study of COVID-19 and Respiratory Tract Infections, sponsored by The Cooper Health System.
NCT04596657 is a NA study of COVID-19 and Respiratory Tract Infections that has completed, run by The Cooper Health System. The registered enrollment target is 877 participants, below the 38,462-participant average among 298 other COVID-19 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04596657, a NA study of COVID-19 and Respiratory Tract Infections, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 877 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3 supplementation can prevent respiratory tract infections, influenza-like illness and covid-19 in hospital workers.
Primary Outcome
Incidence of influenza-like illness
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D supplementation
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 877 participants |
| Start Date | 2020-10-27 |
| Est. Completion | 2023-10-19 |
| Phase | NA |
What the finished NCT04596657 record still lists
NCT04596657 is an interventional study that assigns participants to a tested intervention. The registered 877 participants enrollment target is mid-sized for trials with a published cap, below the 38,462-participant average among 298 other COVID-19 trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D supplementation is the first listed.
NCT04596657 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04596657 about?
NCT04596657 is a clinical study titled "Vitamin D3 Supplementation to Prevent Respiratory Tract Infections". The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3 supplementation can prevent respiratory tract infections, influenza-like illness and covid-19 in hospital workers.
What is the current status of trial NCT04596657?
This trial is currently completed. It is a NA study. The enrollment target is 877 participants. The study started on 2020-10-27. Estimated completion is 2023-10-19.
What conditions does trial NCT04596657 study?
This clinical trial studies the following conditions: COVID-19, Respiratory Tract Infections, Flu Like Illness.
What interventions are being tested in trial NCT04596657?
The interventions under investigation include: Vitamin D supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04596657?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04596657 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04596657's enrollment target sits among peer trials
877 84th of 298 higher than 215 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI